跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Santezon - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Santezon
Approved
STANDARD
Santezon
Furen Pharmaceutical Group Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7b2a940c1aa6d259
Company
Furen Pharmaceutical Group Co., Ltd.
Type
Standard
Approval Details
Approval Id
7b2a940c1aa6d259
Drug Approval Philippines Name
Santezon
Product Name
Santezon
Registration Number
DRP-10961-05
Brand Name
Santezon
Generic Name
Ceftriaxone (as sodium)
Dosage Form
Powder for Injection (I.M./I.V.)
Dosage Strength
1 g
Manufacturer
Furen Pharmaceutical Group Co., Ltd.
Importer
Euro-Care Products Philippines
Distributor
Santerra Trading
Issuance Date
28 March 2024
Expiry Date
22 December 2026
Pharmacologic Category
Antibacterial (Third-generation Cephalosporin)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7b2a940c1aa6d259
Type
Standard
Back to Philippines FDA Approvals